Search results (7)
« Back to NewsOxford University spin-out Quantum Dice wins Institute of Physics business award
18 November 2021
Award Innovation and Enterprise Physics Spin out
Quantum Dice's founders include the Department of Physics’ Ramy Aboushelbaya and Marko Mayr; the company is developing the world’s first compact source-device independent quantum random number generator set to play a key role in the cybersecurity market.
Student start-up CyanoCapture is a winner in $5m XPRIZE for carbon removal projects
16 November 2021
Award Biology Climate MPLS Medical science Plant sciences Spin out
A carbon capture company established less than a year ago by two Oxford students has been announced as one of 23 winners of the XPRIZE student competition.
Oxford Nanopore Technologies floated on the London Stock Exchange
28 October 2021
Chemistry Innovation and Enterprise Spin out
Oxford Nanopore Technologies, a company which began as a spinout from the Department of Chemistry, has floated on the London Stock Exchange. It is the UK's biggest spinout IPO and the 5th biggest worldwide.
Rapid COVID-19 test, Oxsed RaViD Direct, now in use at Heathrow and trials at Hong Kong International Airport
4 November 2020
The spinout company, Oxsed, was last month acquired by DNAFit Life Sciences, a wholly owned entity of Hong Kong-based genetics and diagnostic health testing company Prenetics. Deploying the test to further global airports is now under discussion.
Oxford University creates its 200th spinout company PhishAR
28 October 2020
PhishAR builds on the work of Professor Ivan Martinovic and Dr Ivo Sluganovic from the Department of Computer Science, and employs augmented reality to crack down on “phishing”.
Spin-out company SugaROx to produce and market novel crop stimulant
11 May 2018
Researchers in the Department of Chemistry have developed a crop stimulant that increases yields by 20%.
Oxford 3D bioprinting company OxSyBio secures £10m in funding
13 March 2018
Business and Industry Chemistry Innovation and Enterprise Spin out
OxSyBio, an Oxford University biotech spinout company developing 3D printer technology capable of printing biological materials with a diverse range of therapeutic purposes, has secured £10m in Series A financing from Woodford Investment Management alongside new and existing backers.